Skip to main content

Hyperlipidemia (Primary Prevention) - Lifestyle Changes and/or Lipid Lowering Therapy

CBE ID
0611
Endorsement Status
1.0 New or Maintenance
1.1 Measure Structure
Previous Endorsement Cycle
Is Under Review
No
1.6 Measure Description

Percentage of patients aged 20 years and older with risk factors for coronary artery disease who have an elevated LDL-C and who are taking a lipid lowering agent or have initiated therapeutic lifestyle changes

    Measure Specs
      General Information
      1.14 Numerator

      Patients who are taking lipid lowering therapy or who have initiated therapeutic lifestyle changes.

      1.15 Denominator

      Patients aged 20 and older with risk factors for coronary artery disease who had an elevated LDL-C in the past 12 months.

      Exclusions

      SPECIFIC EXCLUSIONS:
      • Presence of TSH Labs Result Value > 10 In the past 6 Months
      • Presence of NEPHROTIC SYNDROME in past 12 months
      • CAD Validation is confirmed
      • Diabetes Validation is confirmed
      • PAD Validation is confirmed
      • AAA in the past
      • Carotid endarterectomy in the past

      GENERAL EXCLUSIONS:
      • Evidence of metastatic disease or active treatment of malignancy (chemotherapy or radiation therapy) in the last 6 months;
      • Patients who have been in a skilled nursing facility in the last 3 months
      • Patient or provider feedback indicating allergy, intolerance or contraindication to the drug in the past

      Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed National Voluntary Consensus Standards For Clinically Enriched Administrative Data
      Initial Endorsement
      Last Updated
      Removal Date
      Steward Organization
      ActiveHealth Management
      Steward POC email
      mvemireddy@activehealth.net
                Public Comments